Hearing Impairment of Nasopharyngeal Carcinoma

NCT05330169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-07-17

No results posted yet for this study

Summary

This observational cohort study was aimed to evaluate the hearing toxicity at multiple time points from baseline to 1 year after radical chemoradiotherapy among nasopharyngeal carcinoma patients.

Conditions

  • Nasopharyngeal Carcinoma

Sponsors & Collaborators

  • Guangxi Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05330169 on ClinicalTrials.gov